← All stocks

NEKTAR THERAPEUTICS

NKTR Net selling
CIK 0000906709 #1869 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$43.48K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$43.48K
2 of 2 sales
Net
−$43.48K
−$43.48K against sales at will

By person

3 insiders · 2 transactions
3.5×

Howard W. Robin holds only 3.5 times base salary in stock. $3.93M of shares against $1.11M in salary for 2025.

Salary from the company's own proxy. The shares are what Howard W. Robin last reported holding, valued at $71.98, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ROBIN HOWARD W
President & CEO
$30.09K (1)
−$30.09K
54,627
$3.93M
Zalevsky Jonathan
Chief R&D Officer
$13.39K (1)
−$13.39K
9,570
$688.85K
Wilson Mark Andrew
Chief Legal Officer
21,585
$1.55M

No percentages here. This company's share count has moved by a factor of 9.8 over the window, from 19,018,573 to 186,103,588 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
ROBIN HOWARD W
18 Aug 2026
President & CEO
Sell
418
$71.98
$30.09K
Zalevsky Jonathan
18 Aug 2026
Chief R&D Officer
Sell
186
$71.98
$13.39K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 0
History held since 2 Sep 2016